DNASENSE ApS: Financial statements 2017
CVR: 36036869
Source: annual report 2017, Danish Business Authority
01/10/2016 – 30/09/2017
DNASENSE ApS (CVR 36036869) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,796,466 and a net result of DKK 673,206 compared with DKK 359,058 the year before. That is an increase of 59.9% compared with the year before. Equity in the 2017 report amounted to DKK 885,902. The solvency ratio was 74.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,796,466
- Profit/Loss
- DKK 673,206
- Equity
- DKK 885,902
- Total Assets
- DKK 1,184,640
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1.8 mio. | 673 t. | 886 t. | 1 |
| 2016 | - | 1.1 mio. | 359 t. | 513 t. | - |
Keep an eye on DNASENSE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout DNASENSE ApS
DNASENSE ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Mads Toft Søndergaard. The board consists of Anders Christian Neto de Sousa Grøn (chair), Anders Mohr Christensen, Henrik Bjørn Nielsen and Manoj Nirmal Dadlani. The company is owned by Clinical-Microbiomics A/S. The company has 15 employees (2018). In 2025, the company reported a gross profit of DKK 7,915,337 and a net result of DKK 894,729. Equity in the 2025 report amounted to DKK 1,639,012.